Posted By admin On 29/12/21
  1. Vaisto Mush
  2. Va Historian
  3. Va History

FDA Approved: Yes (First approved December 5, 2017)
Brand name: Ozempic
Generic name: semaglutide
Dosage form: Injection
Company:Novo Nordisk
Treatment for:Diabetes, Type 2, Cardiovascular Risk Reduction

Vaisto’s IoT Snapshot maps the range and focus areas of Vaisto’s IoT business across Technologies, Use Cases, Industries, and Services. Only categories with active products will be shown. Missing categories indicate that there is no activity in those areas. Possessive forms of vaisto (type valo) possessor singular plural 1st person vaistoni: vaistomme: 2nd person vaistosi: vaistonne: 3rd person vaistonsa: Anagrams. The u/Vaisto community on Reddit. Reddit gives you the best of the internet in one place.

Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog indicated:

Vaisto Mush

  • as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
  • to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease.

Va Historian


Va History

Development Timeline for Ozempic

Jan 16, 2020ApprovalFDA Approves Ozempic (semaglutide) for Cardiovascular Risk Reduction in Adults with Type 2 Diabetes and Known Heart Disease
Dec 5, 2017ApprovalNovo Nordisk Receives FDA Approval of Ozempic (semaglutide) Injection For the Treatment of Adults with Type 2 Diabetes
Oct 18, 2017Novo Nordisk Receives Positive 16-0 vote from FDA Advisory Committee in Favor of Approval for Semaglutide
Dec 5, 2016Novo Nordisk Files for Regulatory Approval of Once-Weekly Semaglutide with the FDA for the Treatment of Type 2 Diabetes

See Also

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.